RP

Rajesh Phoolchand Joriya

Active Director Director DIN 11053279
DIN 11053279 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Phoolchand Joriya

Data last updated:

Rajesh Phoolchand Joriya is a Director at Medivax Pharma Private Limited (since 2025).

DIN 11053279
Primary Designation Director
First Appointment 12 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medivax Pharma Private Limited U47720MH2025PTC445563
Director12 Apr 20252025Active

Board colleagues of Rajesh Phoolchand Joriya

NameDINCompanyDesignation
Sanyogita11053280Medivax Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medivax Pharma Private Limited
Premium access

Shareholding and investment profile for Rajesh Phoolchand Joriya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Phoolchand Joriya

Rajesh Phoolchand Joriya currently holds 1 directorship: Medivax Pharma Private Limited (Director, since 12 Apr 2025).

Rajesh Phoolchand Joriya was first appointed on 12 Apr 2025 as Director at Medivax Pharma Private Limited.

The current boards of Rajesh Phoolchand Joriya's companies include Sanyogita (Medivax Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available